Zimmer Hip Replacement Receives New FDA Warning

Zimmer’s hip replacement manufacturing troubles are the focus of a September 19, 2012 FDA warning to the beleaguered company.

The FDA cited Zimmer’s Trilogy Acetabular System hip replacement devices manufacturing process and testing at a Ponce, Puerto Rico facility. The FDA warning letter followed FDA inspection of the plant in June.

Lack Of Testing

Evidently the problem stemmed from a lack of testing, as FDA inspectors were troubled that Zimmer had no testing mechanism to show that Trilogy products matched pre-determined design specifications. Additionally, the FDA noted the absence of quality test manufacturing at the Puerto Rico plant of Trilogy products “that incorporate metallic spikes.”

The warning letter did not restrict production or shipment of the hip devices or require withdrawal of any products from the market, Zimmer said in the filing.

However, Zimmer responded to the issues by saying it has since notified customers of the manufacturing issues, and temporarily stopped producing affected products at the plant after receiving the warning letter. It has now resumed producing Trilogy products that lack metallic spikes, and claims its manufacturing processes in this area now meeting FDA specifications. Separately, Zimmer said it will finish the manufacturing validation process for Trilogy products with the metal spikes within the next few weeks.  But, the FDA must then still sign off on the measure.

The Trilogy hip includes a number of components, starting with a base fiber metal. Patients can subsequently choose a bearing made of polyethylene, metal or ceramic, according to Zimmer’s web promotional materials.

Zimmer also makes a highly controversial metal on metal implant.  And their all-metal hip replacements are among many manufactured by a number of different companies that have been receiving negative attention because of safety concerns. The FDA, for example, is asking 20 device makers, including Zimmer, to explore whether its implants affect patients with dangerously high levels of metal in the blood.

You May Also Like


  • This field is for validation purposes and should be left unchanged.

, , , , , ,

No comments yet.

Leave a Reply

  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Merck’s Falsification of Vaccine Data Exposed

Merk’s dirty little secret has been exposed. A pair of lawsuits, one filed by former employees of Merck and the other by doctors, alleged the company knew its mumps vaccine was less effective than the supposed 95 percent efficiency level. According to court documents the former virologists employed by Merck filed a whistleblower lawsuit four […]

Testosterone Therapy Linked To Heart-Attack, Stroke and Death

Millions of men have turned to testosterone therapy to treat symptoms of aging. However, they may not be aware that they are putting themselves at risk for heart attack or stroke. According to the latest study published in the journal PLOS ONE, researchers report that within 90 days of taking the hormone the risk of […]

What Is Doribax?

According to the FDA the antibacterial drug Doribax, that has been used to treat patients who develop pneumonia on ventilators, carries an increased risk of death and has a lower clinical cure rate by injection compared a similar drug known as Primaxin. What is Doribax? Doribax is an antibiotic that fights serious infections caused by […]

Is Using Tylenol or Ibuprofen During Pregnancy linked to ADHD?

What is a mother to do if she becomes ill during pregnancy?  The risks of consuming common drugs when pregnant are complex.  Although many doctors assure mothers that taking Tylenol is safe, a recent study by JAMA Pediatrics suggests otherwise.  The study found that mothers who used Tylenol for fever reduction while pregnant reported greater […]

Paxil Linked To Breast Cancer

City of Hope Cancer researchers indicate that a new test called the AroER Tri-Screen, desgined to look for drug side effects that could cause cancer, found a potential link between Paxil and breast cancer.  Paxil is a widely prescribed anti depressant. Research Researchers have found that Paxil has a weak estrogen effect that could increase […]

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.